BMP5/7 protect dopaminergic neurons in an alpha-synuclein mouse model of Parkinson's disease

被引：0

作者：

Vitic, Zagorka ^{[1
]}

Safory, Hazem ^{[2
,3
]}

Jovanovic, Vukasin M. ^{[4
]}

Sarusi, Yael ^{[1
]}

Stavsky, Alexandra ^{[1
]}

Kahn, Joy ^{[1
]}

Kuzmina, Alona ^{[5
]}

Toker, Lilah ^{[6
,7
]}

Gitler, Daniel ^{[1
]}

Taube, Ran ^{[5
]}

Friedel, Roland H. ^{[8
]}

Engelender, Simone ^{[2
,3
]}

Brodski, Claude ^{[1
]}

机构：

[1] Ben Gurion Univ Negev, Dept Physiol & Cell Biol, Zlotowski Ctr Neurosci, Fac Hlth Sci, IL-84105 Beer Sheva, Israel

[2] Technion Israel Inst Technol, B Rappaport Fac Med, Dept Biochem, IL-31096 Haifa, Israel

[3] Technion Israel Inst Technol, Inst Med Res, IL-31096 Haifa, Israel

[4] Natl Inst Hlth NIH, Natl Ctr Adv Translat Sci NCATS, Stem Cell Translat Lab SCTL, Rockville, MD 20850 USA

[5] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol Immunol & Genet, Fac Hlth Sci, IL-84105 Beer Sheva, Israel

[6] Haukeland Hosp, Dept Neurol, NeuroSysMed Ctr Excellence Clin Res Neurol Dis, N-5021 Bergen, Norway

[7] Univ Bergen, Dept Clin Med, N-5007 Bergen, Norway

[8] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Neurosci & Neurosurg, New York, NY 10029 USA

来源：

BRAIN | 2021年 / 144卷

基金：

以色列科学基金会;

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页数：6

共 50 条

[31] Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease
Meredith, GE
Totterdell, S
Petroske, E
Cruz, KS
Callison, RC
Lau, YS
BRAIN RESEARCH, 2002, 956 (01) : 156 - 165
[32] Alpha-Synuclein in the Blood of Mice in a Neurotoxic Model of Parkinson’s Disease
V. E. Blokhin
M. V. Ugryumov
Neurochemical Journal, 2021, 15 : 18 - 23
[33] Alpha-Synuclein in the Blood of Mice in a Neurotoxic Model of Parkinson's Disease
Blokhin, V. E.
Ugryumov, M., V
NEUROCHEMICAL JOURNAL, 2021, 15 (01) : 18 - 23
[34] Neuropathology of conditional alpha-synuclein transgenic mouse models of Parkinson's disease
Nuber, S.
Petrasch-Parwez, E.
Winner, B.
Winkler, J.
von Hoersten, S.
Teismann, P.
Schulz, J. B.
Neumann, M.
Fendt, M.
Gellerich, F. N.
Riess, O.
PARKINSONISM & RELATED DISORDERS, 2007, 13 : S122 - S122
[35] Endogenous alpha-synuclein influences the number of dopaminergic neurons in mouse substantia nigra
Garcia-Reitboeck, Pablo
Anichtchik, Oleg
Dalley, Jeffrey W.
Ninkina, Natalia
Tofaris, George K.
Buchman, Vladimir L.
Spillantini, Maria Grazia
EXPERIMENTAL NEUROLOGY, 2013, 248 : 541 - 545
[36] Role of T Cells in an Alpha-Synuclein Model of Parkinson's Disease
Subbarayan, M. S.
Hudson, C.
Litsky, N.
Nash, K.
Bickford, P. C.
CELL TRANSPLANTATION, 2019, 28 (04) : 486 - 487
[37] Characterization of novel alpha-synuclein aggregation model of Parkinson's disease
Singh, A.
Reunanen, S.
Panhelainen, A.
Voutilainen, M.
MOVEMENT DISORDERS, 2020, 35 : S483 - S483
[38] Why is GDNF not protective in the alpha-synuclein model of Parkinson's disease?
Decressac, M.
Mattsson, B.
Bjorklund, A.
MOVEMENT DISORDERS, 2011, 26 : S58 - S58
[39] Olfactory Deficits in an Alpha-Synuclein Fly Model of Parkinson's Disease
Chen, Alex Y.
Xia, Shouzhen
Wilburn, Paul
Tully, Tim
PLOS ONE, 2014, 9 (05):
[40] Neuropathology of conditional alpha-synuclein transgenic mouse models of Parkinson's disease
Nuber, S.
Petrasch-Parwez, E.
Winner, B.
Winkler, J.
von Hoersten, S.
Teismann, P.
Schulz, J. B.
Neumann, M.
Fendt, M.
Gellerich, F. N.
Riess, O.
PARKINSONISM & RELATED DISORDERS, 2007, 13 : S90 - S90

← 1 2 3 4 5 →